Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DNK333 in Women with IBS-D
NCT00699166Phase 2Completed
- Sponsor
- Novartis
- Start
- Apr 2004
- Primary completion
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of DNK333 in Irritable bowel syndrome with diarrhea (IBS-D), sponsored by Novartis. Started Apr 2004; status: completed.
02
Drugs
DNK333
03
Conditions
Irritable bowel syndrome with diarrhea (IBS-D)
Beyond the preview
Go deeper on NCT00699166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00699166.